RBC Capital Maintains Outperform on Pharvaris, Raises Price Target to $62
RBC Capital analyst Nevin Varghese maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $52 to $62.
An expert who studies companies thinks Pharvaris is doing well and raised their target price from $52 to $62. This tells you some people are becoming more hopeful about the company, but it's just one person's thinking, not a guarantee about what will actually happen.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.